gender-related diagnostic issues in, 658
prevalence of, 657
risk and prognostic factors for, 657
Sedative, hypnotic, or an xiolytic intoxication, 
556–557
associated features supporting diagnosis of, 557
diagnostic criteria for, 556
diagnostic features of, 556–557
differential diagnosis of, 557
prevalence of, 557
Sedative-, hypnotic-, or anxiolytic-related 
disorders, 481, 550–560
diagnoses associated with, 482
other sedative-, hypnotic-, or anxiolytic-
induced disorders, 560
sedative, hypnotic, or anxiolytic intoxication, 
556–557sedative, hypnotic, or anxiolytic use disorder, 
550–556
sedative, hypnotic, or anxiolytic withdrawal, 
484, 557–560
unspecified sedative-, hy pnotic-, or anxiolytic-
related disorder, 560
Sedative, hypnotic, or anxiolytic use disorder, 
550–556
associated features supporting diagnosis of, 
553
comorbidity with, 555–556
culture-related diagnostic issues in, 554
development and course of, 553–554
diagnostic criteria for, 550–552
diagnostic features of, 552–553
diagnostic markers for, 554–555
differential diagnosis of, 555
functional consequences of, 555
gender-related diagnostic issues in, 554
prevalence of, 553
risk and prognostic factors for, 554
specifiers for, 552
Sedative, hypnotic, or anxiolytic withdrawal, 484, 
557–560